Plasticity-related serine proteases in the brain (review)

International Journal of Molecular Medicine

Volumn 3, Issue 4, 1999, Pages 405-409

  Yoshida, Shigetaka ^a   Shiosaka, Sadao ^a  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

PAR; Plasmin, neuropsin; Plasminogen activators; Thrombin

Indexed keywords

KALLIKREIN; KLK8 PROTEIN, HUMAN; PLASMINOGEN; PROTEASE-ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 3; SERINE PROTEINASE; THROMBIN; THROMBIN RECEPTOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL; BRAIN; HUMAN; METABOLISM; NERVE CELL PLASTICITY; PHYSIOLOGY; REVIEW;

ANIMALS; BRAIN; HUMANS; KALLIKREINS; NEURONAL PLASTICITY; PLASMINOGEN; RECEPTORS, THROMBIN; SERINE ENDOPEPTIDASES; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0033112711     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.4.405     Document Type: Article

References (55)

1. Monard D: Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth. Trends Neuroci 11: 541-544, 1988.
2. Turgeon VL, Lloyd ED, Wang S, Festoff BW and Houenou LJ: Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures though caspase activation. J Neurosci 18: 6882-6891, 1998.
3. Chen Z-L and Strickland S: Neuronal death in the hippocampus is promoted by plasminogen-catalyzed degradation of laminin. Cell 91: 917-925, 1997.
4. Vu T-KH, Hung DT, Wheaton VI and Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteo-Iytic mechanism of receptor activation. Cell 64: 1057-1068, 1991.
5. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T and Coughlin SR: Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386: 502-506, 1997.
6. Xu W-F, Anderson H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW and Foster D: Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 95: 6642-6646, 1998.
7. Nystedt S, Emilsson K, Wahlestedt C and Sundelin J: Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91: 9208-9212, 1994.
8. Hollenberg MD: Protease-mediated signalling: new paradigms for cell regulation and drug demelopment. Trends Pharmacol Sci 17: 3-6, 1996.
9. Dihanich M, Kaser M, Reinhard E, Cunningham D and Monard D: Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6: 575-581, 1991.
10. Weinstein JR, Gold SJ, Cunningham DD and Gall CM: Cellular localization of thrombin receptor mRNA in rat brain: expression by messecephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci 15: 2906-2919, 1995.
11. Deshepper CF, Bigornia V, Berens ME and Lapointe MC: Production of thrombin and antithrombin III by brain and astroglial cell cultures. Mol Brain Res 11: 355-358, 1991.
12. Soifer SJ, Peters KG, O'Keefe J and Coughlin SR: Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am J Pathol 144: 60-69, 1994.
13. Smith-Swintosky VL, Cheo-Issacs CT, D'Andrea MR, Santulli RJ, Darrow AL and Andrade-Gordon P: Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration. J Neurochem 69: 1890-1896, 1997.
14. D'Andrea MR, Derian CK, Leturcq DBSM, Brunmark A, Ling P, Darrow AL, Santulli RJ, Brass LF and Andrade-Gordon P: Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem 46: 157-164, 1998.
15. Nystedt SEK, Larsson A-K, Strombeck B and Sundelin J: Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem 232: 84-89, 1995.
16. Gurwitz D and Cunningham DD: Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci USA 85: 3440-3444, 1988.
17. Suidan HS, Stone SR, Hemmings BA and Monard D: Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 8: 363-375, 1992.
18. Cavanaugh KP, Gurwitz D, Cunningham DD and Bradshaw RA: Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J Neurochem 54: 1735-1743, 1990.
19. Nelson RB and Siman R: Thrombin and its inhibitors regulate morphological and biochemical differentiation of astrocytes in vitro. Dev Brain Res 54: 93-104, 1990.
20. Tas PWL and Koschel K: Thrombin reverts the b-adrenergic agonist-induced morphological response in rat glioma C6 cells. Exp Cell Res 189: 22-27, 1990.
21. Grabham P and Cunningham DD: Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphotylation. J Neurochem 64: 583-591, 1995.
22. Vaughan PJ, Pike CJ, Cotman CW and Cunningham DD: Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci 15: 5389-5401, 1995.
23. Pike CJ, Vaughan PJ, Cunningham DD and Cotman CW: Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by β-amyloid in vitro. J Neurochem 66: 1374-1382, 1996.
24. Glazner GW, Yadav K, Fitzgerald S, Coven E, Brenneman DE and Nelson PG: Cholinergic stimulation increases thrombin activity and gene expression in cultured mouse muscle. Dev Brain Res 99: 148-154, 1997.
25. Donovan FM and Cunningham DD: Signaling pathway involved in thrombin-induced cell protection. J Biol Chem 21: 12746-12752, 1998.
26. Carroll PM, Tsirka SE, Richards WG, Frohman MA and Strickland S: The mouse tissue plasminogen activator gene 5' flanking region directs appropriate expression in development and a seizure-enhanced response in the CNS. Development 120: 3173-3183, 1994.
27. Verrall S and Seeds NW: Characterization of 1251-tissue plasminogen activator binding to cerebellar granule neurons. J Cell Biol 109: 265-271, 1989.
28. Friedman GC and Seeds NW: Tissue plasminogen activator mRNA expression in granule neurons coincides with their migration in the developing cerebellum. J Comp Neurol 360: 658-670, 1995.
29. Thewke DP and Seeds NW: Expression of hepatocyte growth factor/scatter factor, its receptor, c-met, and tissue-type plasminogen activator during development of the murine olfactory system. J Neurosci 16: 6933-6944, 1996.
30. Sumi Y, Dent MAR, Owen DE, Seeley PJ and Morris RJ: The expression of tissue and urokinase-type plasminogen activators in neural development suggests different modes of proteolytic involvement in neuronal growth. Development 116: 625-637, 1992.
31. Dent MAR, Sumi Y, Morris RJ and Seeley PJ: Urokinase-type plasminogen activator expression by neurons and oligodendrocytes during process outgrowth in developing rat brain. Eur J Neurosci 5: 633-647, 1993.
32. Tsirka SE, Gualandris A, Amaral DG and Strickland S: Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377: 340-344, 1995.
33. Ware JH, Dibenedetto AJ and Pittman RN: Localization of tissue plasminogen activator mRNA in adult rat brain. Brain Res Bull 37: 275-281, 1995.
34. Masos T and Miskin R: mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation. Mol Brain Res 47: 157-169, 1997.
35. Qian Z, Gilbert ME, Colicos MA, Kandel ER and Kuhl D: Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361: 453-457, 1993.
36. Huang Y-Y, Bach ME, Lipp H-P, Zhuo M, Wolfer DP, Hawkins RD, Schoonjans L, Kandel ER, Goodfraind J-M, Mulligan R, Collen D and Carmeliet P: Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc Natl Acad Sci USA 93: 8699-8704, 1996.
37. Frey U, Muler M and Kuhl D: A different form of long-lasting potentiation revealed in tissue plasminogen activator mutant mice. J Neurosci 16: 2057-2063, 1996.
38. Mizutani A, Saito H and Matsuki N: Possible involvement of plasmin in long-term potentiation of rat hippocampal slices. Brain Res 739: 276-281, 1996.
39. Malaga N, Imamura K, Shiomitsu T, Yoshimura Y, Fukamauchi K and Watanabe Y: Enhancement of mRNA expression of tissue-type plasminogen activator by L-thero-3,4-dihydroxyphenylserine in association with ocular dominance plasticity. Neurosci Lett 218: 149-152, 1996.
40. Muller CM and Griesinger CB: Tissue plasminogen activator mediates reverse occlusion plasticity in visual cortex. Nat Neurosci 1: 47-53, 1998.
41. Seeds NW, Williams BL and Bickford PC: Tissue plasminogen activator induction in Purkinje neurons after cerebeller motor learning. Science 270: 1992-1994, 1995.
42. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG and Lipton SA: Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4: 228-231, 1998.
43. Tsirka SE, Rogove AD, Bugge TH, Degen JL and Strickland S: An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17: 543-552, 1997.
44. Tsirka SE, Bugge TH, Degen JL and Strickland S: Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci USA 94: 9779-9781, 1997.
45. Meiri N, Masos T, Rosenblum K, Miskin R and Dudai Y: Over-expression of urokinase-type plasminogen activator in transgenic mice is correlated with impaired learning. Proc Natl Acad Sci USA 91: 3196-3200, 1994.
46. Chen Z-L, Yoshida S, Kato K, Suzuki J, Momota Y, Tanaka T, Lin LP, Nishino H, Kiyama H and Shiosaka S: Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J Neurosci 15: 5088-5097, 1995.
47. Shimizu C, Yoshida S, Shibata M, Kato K, Momota Y, Matsumoto K, Shiosaka T, Midorikawa R, Kamachi T, Kawabe A and Shiosaka S: Characterization of recombinant and brain neuropsin, a plasticity-related serine protease. J Biol Chem 273: 11189-11196, 1998.
48. Suzuki J, Yoshida S, Chen Z-L, Momota Y, Kato K, Hirata A and Shiosaka S: Ontogeny of neuropsin mRNA expression in the mouse brain. Neurosci Res 23: 345-351, 1995.
49. McNamara JO: Cellular and molecular basis of epilepcy. J Neurosci 14: 3413-3425, 1994.
50. Okabe A, Momota Y, Yoshida S, Hirata A, Ito J, Nishino H and Shiosaka S: Kindling induces neuropsin mRNA in the mouse brain. Brain Res 728: 116-120, 1996.
51. Momota Y, Yoshida S, Ito J, Shibata M, Kato K, Sakurai K, Matsumoto K and Shiosaka S: Blockade of neuropsin, a serine protease, ameliorates kindling epilepsy. Eur J Neurosci 10: 760-764, 1998.
52. Gschwend TP, Krueger SR, Kozlov SV, Wolfer DP and Sonderegger P: Neurotrypsin, a novel nultidomain serine protease expressed in the nervous system. Mol Cell Neurosci 9: 207-219, 1997.
53. Scarisbrick IA, Towner MD and Isacksbn PJ: Nervous system-specific expression of a novel serine protese: regulation in the adult rat spinal cord by excitotoxic injury. J Neurosci 17: 8156-8168, 1997.
54. Yamashiro K, Tsuruoka N, Kodama S, Tsujimoto M, Yamamura Y, Tanaka T, Nakazato H and Yamaguchi N: Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim Biophys Acta 1350: 11-14, 1997.
55. Meckelein B, Marshall DCL, Conn K-J, Pietropaolo M, Norstrand WV and Abraham CR: Identification of a novel serine protease-like molecule in human brain. Mol Brain Res 55: 181-197, 1998.